Back
Kymera Therapeutics Vs. Nuvalent Industry Stock Comparison
Buy
60
KYMR
Kymera Therapeutics
Last Price:
46.42
Seasonality Move:
25.63%
Buy
72
NUVL
Nuvalent
Last Price:
102.78
Seasonality Move:
33.12%
Buy
60
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.45. The Score for KYMR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Nuvalent (NUVL)
is a Buy
Is Nuvalent a Buy, Sell or Hold?
- The current Nuvalent [NUVL] share price is $102.69. The Score for NUVL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- NUVL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.45
The current trend is moderately bullish and KYMR is experiencing slight selling pressure.
NUVL Stock Price Chart
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 52.28 | Buy |
| Chaikin Money Flow: | -113869 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NUVL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.89 | Buy |
| Relative Strength Index (14 RSI): | 65.95 | Buy |
| Chaikin Money Flow: | -184974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.71 - 94.69) | Buy |
| Bollinger Bands (100): | (68.67 - 84.95) | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.36 | Buy |
| 20-day SMA: | 47.07 | Sell |
| 50-day SMA: | 44.69 | Buy |
| 200-day SMA: | 36.37 | Buy |
| 8-day EMA: | 46.63 | Sell |
| 20-day EMA: | 46.22 | Buy |
| 50-day EMA: | 43.92 | Buy |
| 200-day EMA: | 36.72 | Buy |
NUVL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.89 | Buy |
| 20-day SMA: | 88.26 | Buy |
| 50-day SMA: | 81.04 | Buy |
| 200-day SMA: | 76.4 | Buy |
| 8-day EMA: | 96.23 | Buy |
| 20-day EMA: | 89.25 | Buy |
| 50-day EMA: | 82.92 | Buy |
| 200-day EMA: | 73.23 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
Nuvalent Earnings Growth & NUVL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.28 per share, and a decrease next year of $0.84 per share.
Kymera Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nuvalent Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||